<<

North Dakota Department of Health Mandatory Reportable Conditions™

~Report within 7 days unless otherwise specified~ ƒ AIDS ƒ (invasive) • Anthrax • ƒ Mumps Arboviral (specify etiology) Nipah virus • Botulism • ƒ Nosocomial outbreaks in institutions • ƒ Pertussis • ƒ • • ƒ Cancer (invasive and in-situ carcinomas) ƒ Poliomyelitis • ƒ CD4 Test Results (any CD4 value) ƒ Pregnancy in person infected with perinatally ƒ Chickenpox (varicella) transmissible disease (such as hepatitis B, HIV, ƒ Chlamydial infection Group B strep, syphilis, etc.) • Psittacosis Clostridium perfringens intoxication • ƒ Creutzfeldt-Jakob disease ƒ Rabies Cryptosporidiosis ƒ Animal ƒ Diphtheria • ƒ Human • Enteric E. coli infection • ƒ Rocky Mountain spotted fever ƒ E. coli O157:H7 ƒ Rubella • ƒ Enterohemorrhagic E. coli • ƒ Enteropathogenic E. coli ƒ Scabies outbreaks in institutions ƒ Enteroinvasive E. coli ƒ Severe Acute Respiratory Syndrome (SARS) • ƒ Enterococcus, Vancomycin-resistant (VRE) • • Foodborne/waterborne outbreaks Smallpox • ƒ Giardiasis ƒ Staphylococcus aureus: • ƒ Methicillin-resistant (MRSA) – invasive sites • ƒ ƒ Vancomycin-resistant and intermediate resistant ƒ influenza (invasive) • (VRSA and VISA) – any site • Hantavirus • Staphylococcus enterotoxin B intoxication • ƒ Hemolytic uremic syndrome ƒ Streptococcal infection (invasive) • ƒ Hepatitis A ƒ Syphilis ƒ Hepatitis B ƒ Tetanus ƒ Hepatitis C Tickborne encephalitis viruses • ƒ HIV infection (any HIV test confirmed by IFA, Tickborne hemorrhagic fevers • Western blot or any HIV detection or isolation) ƒ Toxic Shock Syndrome • ƒ Influenza ƒ Trichinosis ƒ Laboratory incidences with possible release of ƒ Tuberculosis • category A agents or novel influenza virus • ƒ Lead level >10μg/dL ƒ Tumors of the central nervous system ƒ Legionellosis ƒ • ƒ Listeriosis • ƒ Unexplained critical illness/death in otherwise healthy ƒ Lyme disease person ƒ Malaria • ƒ Unusual disease clusters ƒ Measles (rubeola) • Viral hemorrhagic fevers • • Weapons of Mass Destruction suspected event ƒ Meningitis (bacterial – specify etiology) • ƒ Yellow fever •

Report Immediately: 1.800.472.2180 or 701.328.2378 • Send isolate or sample to NDPHL Possible Bioterrorism Agents (CDC classified A, B or C Agent) North Dakota Administrative Code 33-06-01 ™ Statutory authority NDCC 23-07-01 Updated 04-01-2007 North Dakota Department of Health Mandatory Reportable Conditions ~Report within 7 days unless otherwise specified~

Antibiotic Resistant Infections Parasitic Infections ƒ Enterococcus, Vancomycin-resistant (VRE) • Cryptosporidiosis ƒ Staphylococcus aureus : ƒ Giardiasis ƒ Methicillin-resistant (MRSA) – invasive sites• ƒ Trichinosis ƒ Vancomycin-resistant and intermediate resistant (VRSA and VISA) – any site • Zoonotic Diseases Anthrax • Bloodborne/STD Infections Brucellosis • ƒ AIDS Glanders • ƒ Chlamydial infection Hantavirus • ƒ Gonorrhea Nipah virus infections • ƒ Hepatitis B Plague • ƒ Hepatitis C Psittacosis ƒ HIV infection (any HIV test confirmed by IFA, Western Q fever blot or any HIV detection or isolation) ƒ Rabies ƒ Syphilis ƒ Animal

Enteric Illnesses ƒ Human • Tularemia • ƒ Campylobacteriosis • Cholera • Other Bacterial/Viral Infections Enteric E. coli infection • Botulism • ƒ E. coli O157:H7 ƒ Legionellosis ƒ Enterohemorrhagic E. coli Melioidosis • ƒ Enteropathogenic E. coli ƒ Meningitis (bacterial – specify etiology) • ƒ Enteroinvasive E. coli ƒ Meningococcal disease (invasive) • ƒ Hepatitis A ƒ Severe Acute Respiratory Syndrome (SARS) • ƒ Listeriosis • ƒ Streptococcal infection (invasive) • Salmonellosis • ƒ Toxic Shock Syndrome • Shigellosis • ƒ Tuberculosis • ƒ Typhoid fever • Viral hemorrhagic fevers • Vaccine Preventable Diseases Other Reportable Conditions ƒ Chickenpox (varicella) ƒ Cancer (invasive and in-situ carcinomas) ƒ Diphtheria • ƒ Haemophilus influenza (invasive) • ƒ CD4 Test Results (any CD4 value) ƒ Influenza Clostridium perfringens intoxication • ƒ Measles (rubeola) • ƒ Creutzfeldt-Jakob disease ƒ Mumps Foodborne/waterborne outbreaks ƒ Pertussis • ƒ Hemolytic uremic syndrome ƒ Poliomyelitis • ƒ Laboratory incidences with possible release of category ƒ Rubella • A agents or novel influenza virus Smallpox • ƒ Lead level >10μg/dL ƒ Tetanus ƒ Nosocomial outbreaks in institutions ƒ Pregnancy in person infected with perinatally Vectorborne Diseases transmissible disease (such as hepatitis B, HIV, Group B Arboviral Infection (specify etiology) strep, syphilis, etc.) ƒ Lyme disease ƒ Scabies outbreaks in institutions ƒ Malaria • Staphylococcus enterotoxin B intoxication • ƒ Rocky Mountain spotted fever ƒ Tumors of the central nervous system Tickborne encephalitis viruses • ƒ Unusual disease clusters Tickborne hemorrhagic fevers • ƒ Unexplained critical illness/death in otherwise healthy ƒ Yellow Fever • person Weapons of Mass Destruction suspected event

Report Immediately: 1.800.472.2180 or 701.328.2378 • Send isolate or sample to NDPHL Possible Bioterrorism Agents (CDC classified A, B or C Agents) North Dakota Administrative Code 33-06-01 ™ Statutory authority NDCC 23-07-01